Leukaemia UK
Leukaemia UK promotes research into leukaemia and other blood cancers and/or related disorders, and is pioneering the development of improved care and support to those affected . The CIO changed its name from Leuka on 1st November 2019 following a merger. Its partner, Leukaemia UK was previously charity number 1150414.
Financial health, per its FY2025 accounts
The accounts state that Leukaemia UK ended the year with a deficit of £303,831, resulting in total funds decreasing to £2,363,318 from £2,667,149 the previous year. However, the trustees confirm that free reserves of £1,981,000 remain within the stated target range of £1.4 million to £2.1 million, and they are satisfied the charity has adequate resources to continue in operational existence for at least 12 months.
What the accounts disclose
“One employee received employee benefits including termination payments of between £100,000-£109,999k, three employees between £70,000-£79,999, and three employees between £60,000-£69,999.”
“One employee received employee benefits including termination payments of between £100,000-£109,999k, three employees between £70,000-£79,999, and three employees between £60,000-£69,999.”
“The main sources of income came from grants, legacies and donations, including donated goods and services, totalling £3,182,673.”
“Fundraised income during 2025 was achieved with an increase in expenditure from £1,547,592 in 2024 to £1,842,828.”
Year-over-year changes
- Reserves position vs the charity's own policy moved from "above" (FY2024) to "within" (FY2025).
Funders the charity credits
- Anthony Nolan
- NHS Blood and Transplant
Structured financials (annual return, FY ending 31/12/2025)
Register events
- Received assets from another charity (31/03/2014)
Trustees
- Dr Jo Reynolds
- Emma McKinley
- Ian McCafferty
- James Barlow
- James Fairclough
- James Lyons
- Karen Cracknell
- Luke Cripps
- Miriam Jordan Keane
- Professor Alejandro Madrigal
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2025 | £3.6m | £4.1m |
| 31/12/2024 | £4.0m | £3.8m |
| 31/12/2023 | £2.8m | £3.5m |
| 31/12/2022 | £2.9m | £3.1m |
| 31/12/2021 | £1.6m | £1.7m |
Common questions
Is Leukaemia UK financially healthy?
Per its FY2025 accounts: The accounts state that Leukaemia UK ended the year with a deficit of £303,831, resulting in total funds decreasing to £2,363,318 from £2,667,149 the previous year. However, the trustees confirm that free reserves of £1,981,000 remain within the stated target range of £1.4 million to £2.1 million, and they are satisfied the charity has adequate resources to continue in operational existence for at least 12 months. Its FY2025 accounts were audited by Cooper Parry Group Limited.
What does the highest-paid employee of Leukaemia UK earn?
Per its FY2025 accounts, the highest-paid employee was in the £100,001 - £110,000 band, and 7 employees earned over £60,000.
Who funds Leukaemia UK?
Funders whose own accounts filings name Leukaemia UK as a grant recipient include THE PIERREPONT TRUST.
Known funders
| Funder | Year | Amount | Purpose (as stated by the funder) |
|---|---|---|---|
| THE PIERREPONT TRUST | FY2025 | £10k |
Government & lottery funding
| Funder | Date | Amount | Purpose |
|---|---|---|---|
| Community Foundation North East | 13/06/2024 | £1k | Grant to Leukaemia UK |
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE PENNIES FOUNDATION | 2 | £100k |
| BNA CHARITABLE INCORPORATED ORGANISATION | 2 | £28k |
| THE BARBOUR FOUNDATION | 2 | £11k |
| THE FRANK LITCHFIELD GENERAL CHARITABLE TRUST | 2 | £7k |
| SANDRA CHARITABLE TRUST | 2 | £6k |
| MILLS AND REEVE CHARITABLE TRUST | 2 | £3k |
| THE MICHAEL AND ANNA WIX CHARITABLE TRUST | 2 | £400 |
| OGLESBY CHARITABLE TRUST | 1 | £340k |
Charities like this
- LEUKAEMIA CARE
- Blood Cancer UK Research
- Merseyside Against Blood Cancers
- LEUKAEMIA & MYELOMA RESEARCH UK LTD
- CURE LEUKAEMIA
- BLOOD CANCER ALLIANCE
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| Leukaemia UK | £3.6m | £100,001 - £110,000 | 7 | within | 51.8% | no doubt |
| LEUKAEMIA CARE | £2.5m | — | — | above | — | no doubt |
| Blood Cancer UK Research | £21.1m | — | — | unclear | — | no doubt |
| Merseyside Against Blood Cancers | £119k | — | 0 | unclear | — | no doubt |
| LEUKAEMIA & MYELOMA RESEARCH UK LTD | £554k | — | 0 | unclear | — | noted |
| CURE LEUKAEMIA | £3.7m | — | — | unclear | — | no doubt |